This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (8)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Public Health  • Substance Abuse/ Alcoholism  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic

New Findings Raise More Questions

Arch Gen Psychiatry. 2001;58:907-908.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE ARTICLE by Reneman et al¹ in this issue of the ARCHIVES is timely and provocative and highlights several areas of controversy in the fields of substance abuse, drug-induced neurotoxic effects, and neuroimaging. The authors present evidence that the illicit recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy") may cause persistent cognitive deficits^{2, 3, 4, 5, 6, 7, 8, 9} and that these deficits are related to the extent of previous MDMA use. Based on single-photon emission computed tomography (SPECT) imaging with ¹²³I-labeled 2ß-carbomethoxy-3ß-(4-iodophenyl)tropane (ß-CIT), they conclude that MDMA causes neurotoxic injury to cortical serotonin (5-HT) axon terminals that may be reversible. This is the first study to evaluate a separate cohort of previous MDMA users who have abstained from use for longer than 1 year, and thus has the potential to provide information regarding long-term effects of exposure to MDMA.

With respect to cognitive effects of MDMA, there is some question regarding the role of concomitant marijuana use . . . [Full Text of this Article]

RELATED ARTICLE

Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy"): Preliminary Findings
Liesbeth Reneman, Jules Lavalaye, Ben Schmand, Frederik A. de Wolff, Wim van den Brink, Gerard J. den Heeten, and Jan Booij
Arch Gen Psychiatry. 2001;58(10):901-906.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognition in Novice Ecstasy Users With Minimal Exposure to Other Drugs: A Prospective Cohort Study
Schilt et al.
Arch Gen Psychiatry 2007;64:728-736.
ABSTRACT | FULL TEXT  

Ecstasy in the Brain: A Model for Neuroimaging
Hurley et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:125-129.
FULL TEXT